Skip to main content Back to Top
Advertisement

9/3/2019

Mannitol Injection

Products Affected - Description

    • Mannitol injection, BBraun, 200 mg/mL, 250 mL premixed bag, 1 count, NDC 00264-7578-20 - discontinued
    • Mannitol injection, ICU Medical, 200 mg/mL, 250 mL premixed bag, 24 count, NDC 00409-7715-02
    • Mannitol injection, Pfizer, 250 mg/mL, 50 mL vial, 25 count, NDC 00409-4031-01

Reason for the Shortage

    • American Regent is not currently marketing mannitol.
    • Baxter did not provide a reason for the mannitol shortage.
    • BBraun has mannitol 500 mL premixed bags available. The 250 mL premixed bags were discontinued.
    • Fresenius Kabi had mannitol on shortage due to increased demand.
    • ICU Medical has mannitol on shortage due to manufacturing delays.
    • Pfizer has mannitol on shortage due to manufacturing delays.

Available Products

    • Osmitrol injection, Baxter, 200 mg/mL, 250 mL premixed bag, 36 count, NDC 00338-0357-02
    • Osmitrol injection, Baxter, 200 mg/mL, 500 mL premixed bag, 24 count, NDC 00338-0357-03
    • Osmitrol injection, Baxter, 50 mg/mL, 1000 mL premixed bag, 14 count, NDC 00338-0351-04
    • Mannitol injection, BBraun, 200 mg/mL, 500 mL premixed bag, 1 count, NDC 00264-7578-10
    • Mannitol injection, Fresenius Kabi, 250 mg/mL, 50 mL vial, 25 count, NDC 63323-0024-25
    • Mannitol injection, ICU Medical, 200 mg/mL, 500 mL premixed bag, 12 count, NDC 00409-7715-03

Estimated Resupply Dates

    • Pfizer has mannitol 250 mg/mL 50 mL vials available in limited supply.
    • ICU Medical has mannitol 200 mg/mL 250 mL premixed bags on back order and the company estimates a release date of late-September 2019.

Updated

Updated September 3, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created August 16, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins